159 related articles for article (PubMed ID: 22931927)
1. Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa.
Tolar J; Xia L; Lees CJ; Riddle M; McElroy A; Keene DR; Lund TC; Osborn MJ; Marinkovich MP; Blazar BR; Wagner JE
J Invest Dermatol; 2013 Feb; 133(2):562-5. PubMed ID: 22931927
[No Abstract] [Full Text] [Related]
2. Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa - 5-Year Outcomes.
Kueckelhaus M; Rothoeft T; De Rosa L; Yeni B; Ohmann T; Maier C; Eitner L; Metze D; Losi L; Secone Seconetti A; De Luca M; Hirsch T
N Engl J Med; 2021 Dec; 385(24):2264-2270. PubMed ID: 34881838
[TBL] [Abstract][Full Text] [Related]
3. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa.
Dellambra E; Vailly J; Pellegrini G; Bondanza S; Golisano O; Macchia C; Zambruno G; Meneguzzi G; De Luca M
Hum Gene Ther; 1998 Jun; 9(9):1359-70. PubMed ID: 9650620
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.
Benati D; Miselli F; Cocchiarella F; Patrizi C; Carretero M; Baldassarri S; Ammendola V; Has C; Colloca S; Del Rio M; Larcher F; Recchia A
Mol Ther; 2018 Nov; 26(11):2592-2603. PubMed ID: 30122422
[TBL] [Abstract][Full Text] [Related]
5. Impact of laminin 5 beta3 gene versus protein replacement on gene expression patterns in junctional epidermolysis bullosa.
Robbins PB; Sheu SM; Goodnough JB; Khavari PA
Hum Gene Ther; 2001 Jul; 12(11):1443-8. PubMed ID: 11485635
[TBL] [Abstract][Full Text] [Related]
6. [Gene therapy for hereditary bullous epidermolysis].
Meneguzzi G; Ortonne JP
Ann Dermatol Venereol; 2000 Mar; 127(3):329-32. PubMed ID: 10804315
[No Abstract] [Full Text] [Related]
7. [Gene therapy of junctional epidermolysis bullosa].
Kahn A
Med Sci (Paris); 2007 Jan; 23(1):109-10. PubMed ID: 17212944
[No Abstract] [Full Text] [Related]
8. Leading edge: emerging drug, cell, and gene therapies for junctional epidermolysis bullosa.
Keith AR; Twaroski K; Ebens CL; Tolar J
Expert Opin Biol Ther; 2020 Aug; 20(8):911-923. PubMed ID: 32178539
[TBL] [Abstract][Full Text] [Related]
9. Observations of skin grafts derived from keratinocytes expressing selectively engineered mutant laminin-332 molecules.
Sakai N; Waterman EA; Nguyen NT; Keene DR; Marinkovich MP
J Invest Dermatol; 2010 Aug; 130(8):2147-50. PubMed ID: 20393483
[No Abstract] [Full Text] [Related]
10. Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant.
Melo SP; Lisowski L; Bashkirova E; Zhen HH; Chu K; Keene DR; Marinkovich MP; Kay MA; Oro AE
Mol Ther; 2014 Apr; 22(4):725-33. PubMed ID: 24390279
[TBL] [Abstract][Full Text] [Related]
11. Skin: Uncovering Our Covering.
EBioMedicine; 2017 Dec; 26():1. PubMed ID: 29248248
[No Abstract] [Full Text] [Related]
12. Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa.
Dellambra E; Pellegrini G; Guerra L; Ferrari G; Zambruno G; Mavilio F; De Luca M
Hum Gene Ther; 2000 Nov; 11(16):2283-7. PubMed ID: 11084687
[TBL] [Abstract][Full Text] [Related]
13. Successful Multidisciplinary Treatment of Chronic Facial Wounds in Junctional Epidermolysis Bullosa.
Reimer A; Laszig R; Pfeiffer J; Eberwein P; Mittelviefhaus H; Bruckner-Tuderman L; Has C
Acta Derm Venereol; 2018 Jul; 98(7):711-712. PubMed ID: 29963681
[No Abstract] [Full Text] [Related]
14. PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa.
Ortiz-Urda S; Thyagarajan B; Keene DR; Lin Q; Calos MP; Khavari PA
Hum Gene Ther; 2003 Jun; 14(9):923-8. PubMed ID: 12828862
[TBL] [Abstract][Full Text] [Related]
15. Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis Bullosa.
Hammersen J; Has C; Naumann-Bartsch N; Stachel D; Kiritsi D; Söder S; Tardieu M; Metzler M; Bruckner-Tuderman L; Schneider H
J Invest Dermatol; 2016 Nov; 136(11):2150-2157. PubMed ID: 27375110
[TBL] [Abstract][Full Text] [Related]
16. Gene symbol: LAMB3. Disease: junctional epidermolysis bullosa, Herlitz variant.
Schneider H; Muehle C
Hum Genet; 2005 Dec; 118(3-4):545. PubMed ID: 16521295
[No Abstract] [Full Text] [Related]
17. Animal models for skin blistering conditions: absence of laminin 5 causes hereditary junctional mechanobullous disease in the Belgian horse.
Spirito F; Charlesworth A; Linder K; Ortonne JP; Baird J; Meneguzzi G
J Invest Dermatol; 2002 Sep; 119(3):684-91. PubMed ID: 12230513
[TBL] [Abstract][Full Text] [Related]
18. Regeneration of the entire human epidermis using transgenic stem cells.
Hirsch T; Rothoeft T; Teig N; Bauer JW; Pellegrini G; De Rosa L; Scaglione D; Reichelt J; Klausegger A; Kneisz D; Romano O; Secone Seconetti A; Contin R; Enzo E; Jurman I; Carulli S; Jacobsen F; Luecke T; Lehnhardt M; Fischer M; Kueckelhaus M; Quaglino D; Morgante M; Bicciato S; Bondanza S; De Luca M
Nature; 2017 Nov; 551(7680):327-332. PubMed ID: 29144448
[TBL] [Abstract][Full Text] [Related]
19. Junctional epidermolysis bullosa keratinocytes in culture display adhesive, structural, and functional abnormalities.
Krueger JG; Lin AN; Leong I; Carter DM
J Invest Dermatol; 1991 Nov; 97(5):849-61. PubMed ID: 1717612
[TBL] [Abstract][Full Text] [Related]
20. Keratinocytes from junctional epidermolysis bullosa do adhere and migrate on the basement membrane protein nicein through alpha 3 beta 1 integrin.
Verrando P; Lissitzky JC; Sarret Y; Winberg JO; Gedde-Dahl T; Schmitt D; Bruckner-Tuderman L
Lab Invest; 1994 Oct; 71(4):567-74. PubMed ID: 7967512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
